Effect of OPC-12759, a Novel Antiulcer Agent on Chronic and Acute Experimental Gastric Ulcer, and Gastric Secretion in Rats-Reference-Cited by-同舟云学术

Effect of OPC-12759, a Novel Antiulcer Agent on Chronic and Acute Experimental Gastric Ulcer, and Gastric Secretion in Rats

Published:1989 Issue:4 Volume:49 Page:441-448
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

YAMASAKI Katsuya,ISHIYAMA Hironobu,IMAIZUMI Takashi,KANBE Toshimi,YABUUCHI Youichi

Publisher

Elsevier BV

Subject

Pharmacology

Reference33 articles.

1. Studies on 2(1 H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-chlorobenzoylamino)-3-[2(1 H)-quinolinon-4-yl]propionic acid and related compounds;Uchida;Chem. Pharm. Bull. (Tokyo),1985

2. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat;Yamasaki;Eur. J. Pharmacol.,1987

3. Healing promoting effect of proamipide, a novel drug to increase gastric defense mechanisms, on acetic acid-induced gastric ulcers in the rat;Shiraki;Folia Pharmacol. Japon,1988

4. Antiulcer effect and pharmacological properties of 4-(2-carboxyethyl)phenyl trans 4-amino-methylcyclohexanecarboxylate hydrochloride (DV-1006);Hashizume;Pharmacometrics,1976

5. Chronicity of acetic acid ulcer in the rat stomach;Okabe;Dig. Dis.,1972

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial;BMC Ophthalmology;2023-08-03

2. Mineral Water Vincentka and its Influence on Mucosal Ulcers;Physiological Research;2022-12-30

3. The effect of rebamipide on non-steroidal anti-inflammatory drug-induced gastro-enteropathy: a multi-center, randomized pilot study;The Korean Journal of Internal Medicine;2022-11-01

4. Use of rebamipide gastroprotector agent in clinical practice;Glavvrač (Chief Medical Officer);2022-07-01

5. Gastroprotectant Rebamipide: review of action mechanisms and clinical applications;Glavvrač (Chief Medical Officer);2022-03-20